Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis
- PMID: 27900955
- DOI: 10.4103/1319-2442.194593
Serum levels of N-terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis
Abstract
The objective of this study was to determine the diagnostic cutoff value of N-terminal-pro B-type natriuretic peptide (NT-pro BNP) as a marker of left ventricular (LV) dysfunction in children with end-stage renal disease (ESRD) on regular hemodialysis (HD). The study was carried out on thirty children with ESRD on regular HD and thirty healthy controls. Echocardiographic studies were done, including a conventional mode for ejection fraction, fractional shortening, tissue Doppler imaging, and longitudinal global strain by speckle tracking. Serum levels of NT-pro BNP were measured in venous blood samples before and about 30 min after HD by ELISA. Volume status was assessed by calculating interdialytic weight gain %. There were significant higher serum NT-pro BNP levels before HD (mean: 702.3 ± 274.3 ng/L) compared to controls (mean: 365.55 ± 76.5 ng/L) (P <0.001) and these levels decreased significantly after the HD session (mean: 625.1 ± 117.69 ng/L) (P = 0.031). Echocardiographic studies showed a significant impairment of LV function of the patients compared to controls. Patients with LV dysfunction had significant higher serum concentrations of NT-pro BNP compared to patients without dysfunction both before (P = 0.003) and after dialysis (P <0.001). Receiver operating curve demonstrated better prediction of LV dysfunction by NT-pro BNP levels after HD compared to its levels before HD (area under the curve was 0.9 and 0.73, respectively). Using a cutoff value of 630 ng/L, serum NT-pro BNP levels after dialysis were a diagnostic predictor of LV dysfunction with a sensitivity of 86.6%, specificity of 93.3%, positive predictive value of 92.8%, and negative predictive value of 87.5%. Serum NT-pro BNP levels were strongly correlated with the parameters of LV dysfunction in children with ESRD on regular HD. A postdialysis cutoff value of 630 ng/L could serve as a biochemical marker of LV dysfunction in those children regardless of chronic fluid overload.
Similar articles
-
Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.Nephrol Dial Transplant. 2008 Apr;23(4):1370-7. doi: 10.1093/ndt/gfm700. Epub 2007 Dec 18. Nephrol Dial Transplant. 2008. PMID: 18089624
-
Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.Clin Biochem. 2006 Jun;39(6):640-5. doi: 10.1016/j.clinbiochem.2006.01.021. Epub 2006 Mar 3. Clin Biochem. 2006. PMID: 16516185
-
Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.Perit Dial Int. 2006 May-Jun;26(3):360-5. Perit Dial Int. 2006. PMID: 16722030
-
[Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].Arch Mal Coeur Vaiss. 2004 Sep;97(9):881-8. Arch Mal Coeur Vaiss. 2004. PMID: 15521481 Review. French.
-
The effect of hemodialysis on N-terminal pro-brain natriuretic peptide: A systematic review and meta-analysis.Am J Emerg Med. 2021 Jun;44:244-249. doi: 10.1016/j.ajem.2020.03.056. Epub 2020 Apr 1. Am J Emerg Med. 2021. PMID: 32327248
Cited by
-
Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients.Front Cardiovasc Med. 2021 Feb 22;8:646402. doi: 10.3389/fcvm.2021.646402. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33693039 Free PMC article.
-
Prognostic impact of albumin-bilirubin score on the prediction of in-hospital mortality in patients with heart failure: a retrospective cohort study.BMJ Open. 2022 Jan 4;12(1):e049325. doi: 10.1136/bmjopen-2021-049325. BMJ Open. 2022. PMID: 34983753 Free PMC article.
-
Heart failure biomarkers in hemodialysis patients.Cardiol J. 2024;31(4):628-636. doi: 10.5603/cj.92167. Epub 2024 Jul 12. Cardiol J. 2024. PMID: 38994825 Free PMC article. Review.
-
Assessment of fluid status in neonatal dialysis: the need for new tools.Pediatr Nephrol. 2023 Apr;38(4):1373-1379. doi: 10.1007/s00467-022-05829-2. Epub 2022 Dec 2. Pediatr Nephrol. 2023. PMID: 36459242 Free PMC article.
-
Left ventricular dysfunction by conventional and tissue Doppler echocardiography in pediatric hemodialysis patients: relation with plasma brain natriuretic peptide levels.Arch Med Sci Atheroscler Dis. 2018 Feb 7;3:e18-e28. doi: 10.5114/amsad.2018.73277. eCollection 2018. Arch Med Sci Atheroscler Dis. 2018. PMID: 30775585 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous